Paul Jones

Summary

Affiliation: St George's Hospital Medical School
Country: UK

Publications

  1. pmc Health status measurement in chronic obstructive pulmonary disease
    P W Jones
    Department of Respiratory Medicine, Division of Physiological Medicine, St George s Hospital Medical School, London SW17 0RE, UK
    Thorax 56:880-7. 2001
  2. ncbi request reprint St. George's Respiratory Questionnaire: MCID
    Paul W Jones
    St George s Hospital Medical School, London, UK
    COPD 2:75-9. 2005
  3. ncbi request reprint Clinical effects of inhaled corticosteroids in chronic obstructive pulmonary disease
    Paul W Jones
    Respiratory Medicine, St George s Hospital Medical School, London SW 17 0RE, UK
    Proc Am Thorac Soc 1:167-70. 2004
  4. ncbi request reprint Activity limitation and quality of life in COPD
    Paul W Jones
    St George s, University of London, London, United Kingdom
    COPD 4:273-8. 2007
  5. doi request reprint Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe
    Paul W Jones
    Division of Clinical Science, St George s, University of London, London, UK
    Prim Care Respir J 21:329-36. 2012
  6. pmc COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population
    Monica J Fletcher
    Education for Health, Warwick, UK
    BMC Public Health 11:612. 2011
  7. doi request reprint Properties of the COPD assessment test in a cross-sectional European study
    P W Jones
    Division of Clinical Science, St George s University of London, Cranmer Terrace, London SW17 0RE, UK
    Eur Respir J 38:29-35. 2011
  8. doi request reprint Health-related quality of life in patients by COPD severity within primary care in Europe
    P W Jones
    Division of Clinical Science, St George s University of London, London, UK
    Respir Med 105:57-66. 2011
  9. ncbi request reprint Measuring the effects of COPD on the patient
    Paul Jones
    St George s Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK
    Respir Med 99:S11-8. 2005
  10. ncbi request reprint An introduction to systematic reviews in respiratory medicine
    P W Jones
    Division of Physiological Medicine, St George s Hospital Medical School, London, UK
    Respir Med 97:97-103. 2003

Detail Information

Publications39

  1. pmc Health status measurement in chronic obstructive pulmonary disease
    P W Jones
    Department of Respiratory Medicine, Division of Physiological Medicine, St George s Hospital Medical School, London SW17 0RE, UK
    Thorax 56:880-7. 2001
    ..Finally, it addresses the question of how symptomatic benefit may be assessed in individual patients in routine practice...
  2. ncbi request reprint St. George's Respiratory Questionnaire: MCID
    Paul W Jones
    St George s Hospital Medical School, London, UK
    COPD 2:75-9. 2005
    ....
  3. ncbi request reprint Clinical effects of inhaled corticosteroids in chronic obstructive pulmonary disease
    Paul W Jones
    Respiratory Medicine, St George s Hospital Medical School, London SW 17 0RE, UK
    Proc Am Thorac Soc 1:167-70. 2004
    ..The effect of fluticasone on health appears to be due to a reduction in exacerbations coupled with its small effect on FEV(1)...
  4. ncbi request reprint Activity limitation and quality of life in COPD
    Paul W Jones
    St George s, University of London, London, United Kingdom
    COPD 4:273-8. 2007
    ..This suggests that self-reported limitation of activity may form a reliable construct, and may also provide a good surrogate marker of health status in COPD...
  5. doi request reprint Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe
    Paul W Jones
    Division of Clinical Science, St George s, University of London, London, UK
    Prim Care Respir J 21:329-36. 2012
    ..Most patients with chronic obstructive pulmonary disease (COPD) in Europe are treated in primary care, but perceptions on what guides primary care physicians (PCPs) in managing patients are lacking...
  6. pmc COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population
    Monica J Fletcher
    Education for Health, Warwick, UK
    BMC Public Health 11:612. 2011
    ..The burden of disease is known to be high, though less is known about those of a younger age. The aim of this study was to investigate the wider personal, economic and societal burden of COPD on a cross country working-age cohort...
  7. doi request reprint Properties of the COPD assessment test in a cross-sectional European study
    P W Jones
    Division of Clinical Science, St George s University of London, Cranmer Terrace, London SW17 0RE, UK
    Eur Respir J 38:29-35. 2011
    ..8, p<0.0001). The CAT is a simple and easy-to-use questionnaire that distinguishes between patients of different degrees of COPD severity and appears to behave the same way across countries...
  8. doi request reprint Health-related quality of life in patients by COPD severity within primary care in Europe
    P W Jones
    Division of Clinical Science, St George s University of London, London, UK
    Respir Med 105:57-66. 2011
    ..Within each GOLD stage of severity there is considerable heterogeneity in HRQL impairment among patients. (Study number: 111749)...
  9. ncbi request reprint Measuring the effects of COPD on the patient
    Paul Jones
    St George s Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK
    Respir Med 99:S11-8. 2005
    ..Future developments will include computerising these methodologies to permit faster and more individual patient-centred measurements...
  10. ncbi request reprint An introduction to systematic reviews in respiratory medicine
    P W Jones
    Division of Physiological Medicine, St George s Hospital Medical School, London, UK
    Respir Med 97:97-103. 2003
    ....
  11. ncbi request reprint Cost-effectiveness of salmeterol in patients with chronic obstructive pulmonary disease: an economic evaluation
    P W Jones
    Division of Physiological Medicine, St George s Hospital Medical School, London, UK
    Respir Med 97:20-6. 2003
    ..Addition of salmeterol to COPD patients' current therapy improved lung function, health status at the expense of a modest increase in costs compared with usual therapy...
  12. ncbi request reprint Methodological issues in evaluating measures of health as outcomes for COPD
    P W Jones
    St George s Hospital Medical School, London, UK
    Eur Respir J Suppl 41:13s-18s. 2003
    ..Utility-based measures help address concerns regarding clinical versus statistical improvement and place outcomes for chronic obstructive pulmonary disease treatment trials in the context of all healthcare treatments...
  13. ncbi request reprint Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations
    P W Jones
    Division of Physiological Medicine, St George s Hospital Medical School, London, UK
    Eur Respir J 21:68-73. 2003
    ....
  14. ncbi request reprint Applying evidence and theory to guide clinical decision making--implications for asthma management
    P W Jones
    St George s Hospital Medical School, Cranmer Terrace, London SW17 0RE, U K
    Respir Med 96:567-71. 2002
    ..However, this process can be facilitated by physician education and participation in intervention programmes. In addition, it is important that clinicians are trained in how to convey the best possible evidence to their asthma patients...
  15. ncbi request reprint Interpreting thresholds for a clinically significant change in health status in asthma and COPD
    P W Jones
    St George s Hospital Medical School, London, UK
    Eur Respir J 19:398-404. 2002
    ..Finally, an attempt is made to translate these thresholds into scenarios that illustrate what a clinically significant change with treatment may mean to an individual patient...
  16. pmc Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement
    Paul Jones
    Division of Clinical Science, University of London, London, UK
    Int J Chron Obstruct Pulmon Dis 7:697-709. 2012
    ..In turn, this will help us to understand better the patient's experience of the disease...
  17. pmc Retrospective cohort study of false alarm rates associated with a series of heart operations: the case for hospital mortality monitoring groups
    Jan Poloniecki
    Community Health Sciences, St George s Hospital Medical School, London SW17 0RE
    BMJ 328:375. 2004
    ..To examine the efficacy of different methods of detecting a high death rate and determining whether an increase in deaths after heart transplantation could be explained by chance...
  18. doi request reprint Predicting EQ-5D values using the SGRQ
    Helen J Starkie
    National Institute for Health and Clinical Excellence, London, UK
    Value Health 14:354-60. 2011
    ..George's Respiratory Questionnaire (SGRQ) in subjects with chronic obstructive pulmonary disease and to examine the effect of using this algorithm in predicting quality-adjusted life-years (QALYs)...
  19. doi request reprint Improving the process and outcome of care in COPD: development of a standardised assessment tool
    Paul Jones
    Department of Cardiac and Vascular Sciences, St George s Hospital, University of London, London, UK
    Prim Care Respir J 18:208-15. 2009
    ..This goal requires regular systematic assessment of the patient's COPD with clear and efficient communication between the patient and clinician...
  20. doi request reprint Utility estimation in chronic obstructive pulmonary disease: a preference for change?
    Jennifer Petrillo
    Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK
    Pharmacoeconomics 29:917-32. 2011
    ..The trade-off allows relevant and sensitive matters most important to patients to be evaluated; however inevitable gaps such as those related to adverse events are not considered...
  21. ncbi request reprint Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire
    Makiko Meguro
    Cardiac and Vascular Sciences, St George s, University of London, Cranmer Terrace, London, UK
    Chest 132:456-63. 2007
    ..To produce an improved, COPD-specific version of the St. George respiratory questionnaire (SGRQ-C)...
  22. doi request reprint Health status and the spiral of decline
    Paul W Jones
    St George s, University of London, Cranmer Terrace, London, UK
    COPD 6:59-63. 2009
    ..Inhaled corticosteroids have been shown to reduce the rate of decline of health status, possibly due to exacerbation prevention...
  23. doi request reprint Aclidinium bromide twice daily for the treatment of chronic obstructive pulmonary disease: a review
    Paul Jones
    St George s University of London, Cranmer Terrace, London, SW17 0RE, UK
    Adv Ther 30:354-68. 2013
    ..i.d. is effective for the treatment of patients with COPD, offering improvements in lung function, breathlessness, and HRQoL, with a good safety profile and a low incidence of anticholinergic and cardiac AEs...
  24. ncbi request reprint Quantifying of severity of exacerbations in chronic obstructive pulmonary disease: adaptations to the definition to allow quantification
    Paul Jones
    St George s, University of London, Cranmer Terrace, London, SW17 0RE, UK
    Proc Am Thorac Soc 4:597-601. 2007
    ..Methods for defining exacerbation onset and cessation are also proposed...
  25. ncbi request reprint The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease: a randomized crossover trial
    Elizabeth A Laude
    Respiratory Medicine, Royal Hallamshire Hospital, Department of General Practice and Primary Care, ScHARR, Biomedical Sciences, University of Sheffield, Sheffield, UK
    Am J Respir Crit Care Med 173:865-70. 2006
    ..Replacing nitrogen with helium reduces expiratory flow resistance and may improve lung emptying. Combining these treatments should be independently effective...
  26. ncbi request reprint Corticosteroid therapy in pulmonary sarcoidosis: a systematic review
    Shanthi Paramothayan
    Division of Physiological Medicine, St George s Hospital Medical School, Cranmer Terrace, London SW17 ORE, England
    JAMA 287:1301-7. 2002
    ..Spontaneous recovery is a common feature. Both the decision to initiate therapy and the treatment response may be influenced by disease severity, so trials need to use a randomized controlled design...
  27. ncbi request reprint Adapting to asthma: are some asthma effects acceptable?
    Elizabeth A Barley
    Department of Medicine, Respiratory Medicine, Cardiac and Vascular Sciences, St George s, University of London, London, United Kingdom
    J Asthma 43:433-8. 2006
    ..We conclude that patients accept some asthma effects but do not appear to discount them when using a detailed health status questionnaire...
  28. ncbi request reprint Repeatability of a Rasch model of the AQ20 over five assessments
    Elizabeth A Barley
    Division of Physiological Medicine, Department of Medicine, St George s, University of London, Cranmer Terrace, SW17 0RE, London, UK
    Qual Life Res 15:801-9. 2006
    ..This is important as inclusion of 'time-dependent' items in a questionnaire may reduce the reliability of the instrument...
  29. doi request reprint Symptom measurement
    Paul W Jones
    Chest 134:226-7. 2008
  30. doi request reprint It's about time--directing our attention toward modifying the course of COPD
    Mario Cazzola
    University of Rome Tor Vergata, Department of Internal Medicine, Unit of Respiratory Diseases, Rome, Italy
    Respir Med 102:S37-48. 2008
    ..In this review we have considered three approaches toward modifying the course of COPD: smoking cessation, reduction in lung hyperinflation through medical and surgical approaches, and long-term pharmacotherapy...
  31. ncbi request reprint Brazilian version of airways questionnaire 20: a reproducibility study and correlations in patients with COPD
    Aquiles Camelier
    Pulmonary Division, Rehabilitation Center, Federal University of Sao Paulo, SP, Brazil
    Respir Med 99:602-8. 2005
    ..It can be concluded that AQ20 is reproducible, with an excellent correlation with SGRQ total score, and also having the advantage of taking just a few minutes to be applied and to have its score calculated...
  32. ncbi request reprint Health status: what does it mean for payers and patients?
    Paul W Jones
    St George s, University of London, UK
    Proc Am Thorac Soc 3:222-6. 2006
    ..Improved health does not improve mortality or morbidity per se. It is also important to appreciate that the impact of any measured change in health may also be determined by the patient's baseline state...
  33. ncbi request reprint Evaluation of male COPD patients' health status by proxies
    Carme Santiveri
    Respiratory Department, Dos de Maig Hospital, Consorci Sanitari Integral, Barcelona 08025, Catalonia, Spain
    Respir Med 101:439-45. 2007
    ..The aim of this study was to analyse the reliability and validity of the St. George's Respiratory Questionnaire (SGRQ) answered by proxies and to determine their accuracy as raters...
  34. ncbi request reprint Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
    Peter M A Calverley
    University Hospital Aintree, Liverpool, United Kingdom
    N Engl J Med 356:775-89. 2007
    ..Long-acting beta-agonists and inhaled corticosteroids are used to treat chronic obstructive pulmonary disease (COPD), but their effect on survival is unknown...
  35. ncbi request reprint Withdrawal from treatment as an outcome in the ISOLDE study of COPD
    Peter M A Calverley
    Department of Medicine, University Hospital Aintree, Liverpool, United Kingdom
    Chest 124:1350-6. 2003
    ..To investigate the determinants of patient withdrawal from our study, and the effect of these withdrawals on the outcome of treatment with inhaled corticosteroids in patients with COPD...
  36. pmc The severity of airways obstruction as a determinant of treatment response in COPD
    Peter Calverley
    Clinical Research Centre, University Hospital Aintree, Liverpool, UK
    Int J Chron Obstruct Pulmon Dis 1:209-18. 2006
    ....
  37. doi request reprint Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study
    Bartolome R Celli
    Tufts University School of Medicine, Pulmonary and Critical Care Division, Caritas St Elizabeth s Medical Center, Boston, MA 02135 2997, USA
    Am J Respir Crit Care Med 178:332-8. 2008
    ..Chronic obstructive pulmonary disease (COPD) is characterized by an accelerated decline in lung function. No drug has been shown conclusively to reduce this decline...
  38. ncbi request reprint Health-related quality of life in patients with chronic respiratory failure after long-term mechanical ventilation
    Sara Euteneuer
    Krankenhaus Kloster Grafschaft, Schmallenberg, Germany
    Respir Med 100:477-86. 2006
    ..This study was aimed at assessing health-related quality of life (HRQL) in patients with chronic respiratory failure (CRF) and long-term survival following prolonged intensive care mechanical ventilation...
  39. ncbi request reprint Measuring functional performance in patients with COPD: a discussion of patient-reported outcome measures
    Donald E Stull
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Curr Med Res Opin 23:2655-65. 2007
    ....